» Articles » PMID: 24103304

Gold Nanoparticle Mediated Cancer Immunotherapy

Overview
Journal Nanomedicine
Publisher Elsevier
Date 2013 Oct 10
PMID 24103304
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

From The Clinical Editor: Cancer immunotherapy approaches are rapidly evolving and are some of the most promising avenues to approach malignancies. This review summarizes the role of gold nanoparticles in immunotherapy agent delivery, and in the development of synergistic therapies such as photothermal ablation.

Citing Articles

Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells.

Szwed M, Jost T, Majka E, Gharibkandi N, Majkowska-Pilip A, Frey B Int J Mol Sci. 2025; 26(4).

PMID: 40004038 PMC: 11855494. DOI: 10.3390/ijms26041574.


Monosaccharide coating modulate the intracellular trafficking of gold nanoparticles in dendritic cells.

Alobaid M, Richards S, Alexander M, Gibson M, Ghaemmaghami A Mater Today Bio. 2024; 29:101371.

PMID: 39698001 PMC: 11652954. DOI: 10.1016/j.mtbio.2024.101371.


Inorganic Nanoparticle Functionalization Strategies in Immunotherapeutic Applications.

Mao W, Yoo H Biomater Res. 2024; 28:0086.

PMID: 39323561 PMC: 11423863. DOI: 10.34133/bmr.0086.


Impact of synthesis methods on the functionality of antibody-conjugated gold nanoparticles for targeted therapy.

Anaki A, Tzror-Azankot C, Motiei M, Sadan T, Popovtzer R Nanoscale Adv. 2024; .

PMID: 39247853 PMC: 11372556. DOI: 10.1039/d4na00134f.


Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines.

Zhang W, Zheng X, Coghi P, Chen J, Dong B, Fan X Front Immunol. 2024; 15:1438030.

PMID: 39206192 PMC: 11349682. DOI: 10.3389/fimmu.2024.1438030.


References
1.
Ito A, Honda H, Kobayashi T . Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother. 2005; 55(3):320-8. PMC: 11030207. DOI: 10.1007/s00262-005-0049-y. View

2.
Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schaffler M . Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm. 2011; 77(3):407-16. PMC: 3051057. DOI: 10.1016/j.ejpb.2010.12.029. View

3.
Poon L, Zandberg W, Hsiao D, Erno Z, Sen D, Gates B . Photothermal release of single-stranded DNA from the surface of gold nanoparticles through controlled denaturating and Au-S bond breaking. ACS Nano. 2010; 4(11):6395-403. DOI: 10.1021/nn1016346. View

4.
Perrault S, Walkey C, Jennings T, Fischer H, Chan W . Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009; 9(5):1909-15. DOI: 10.1021/nl900031y. View

5.
Fallarini S, Paoletti T, Orsi Battaglini C, Ronchi P, Lay L, Bonomi R . Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles. Nanoscale. 2012; 5(1):390-400. DOI: 10.1039/c2nr32338a. View